Effect and mechanism of zoledronate on prevention of collapse in osteonecrosis of the femoral head.
- Author:
Meng FAN
1
;
Wen-xue JIANG
;
Ai-yuan WANG
;
Yu WANG
;
Jiang PENG
;
Li ZHANG
;
Wen-jing XU
;
Shi-bi LU
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Diphosphonates; therapeutic use; Disease Models, Animal; Femur Head; drug effects; pathology; Femur Head Necrosis; drug therapy; pathology; Imidazoles; therapeutic use; Male; Osteoblasts; drug effects; pathology; Osteoclasts; drug effects; pathology; Rats; Rats, Sprague-Dawley
- From: Acta Academiae Medicinae Sinicae 2012;34(4):330-336
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo observe the effect and mechanism of zoledronate on prevention of collapse in an animal model of osteonecrosis.
METHODSIschemic osteonecrosis was surgically induced in 16 SD rats (which were further divided into zoledronate group and placebo group); another 8 rats were used as sham surgery group (n=8). The animals were killed 5 weeks after surgery. Radiographic, Micro-CT, histological, and immunohistochemical assessments were performed.
RESULTSRadiographic assessment showed better preservation of the femoral head shape in the zoledronate group than in the placebo group but not significantly different from the sham surgery group. Micro-CT assessment showed higher total volume, bone volume, and total mineralized content in the zoledronate group(all P0.05). Compared with the placebo group, the zoledronate group had reduced osteoclast and osteoblast activity, as confirmed by histological examinations.
CONCLUSIONZoledronate can decrease the femoral head deformity by reducing the osteoclast activity while suppressing new bone and vessels formation in a rat model of traumatic osteonecrosis, and therefore may delay the collapse of femoral head.
